About this project
Under the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), this project aims to develop the world’s highest performance mass spectrometry system. The system will be used to find biomarkers and candidate target molecules in order to establish new diagnostic and treatment methods for breast and esophageal cancer and for Alzheimer’s disease.
When practical technologies become available in near future, the discovery research of new biomarkers for diagnostic and therapeutic use will be greatly accelerated to achieve healthier and longer life for all.
* Though this project ended in March 2014, research results and new information continued to be posted until March 20, 2015. However, the site is no longer updated.